These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20519358)

  • 1. Cancer-testis antigens and immunosurveillance in human cutaneous squamous cell and basal cell carcinomas.
    Walter A; Barysch MJ; Behnke S; Dziunycz P; Schmid B; Ritter E; Gnjatic S; Kristiansen G; Moch H; Knuth A; Dummer R; van den Broek M
    Clin Cancer Res; 2010 Jul; 16(14):3562-70. PubMed ID: 20519358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas.
    Dumas V; Kanitakis J; Charvat S; Euvrard S; Faure M; Claudy A
    Anticancer Res; 1999; 19(4B):2929-38. PubMed ID: 10652575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy for nonmelanoma skin cancer: does it have a future?
    Urosevic M; Dummer R
    Cancer; 2002 Jan; 94(2):477-85. PubMed ID: 11900233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine Pam 212 cutaneous squamous cell carcinoma is nonimmunogenic in normal syngeneic hosts and resistant to immune effector mechanisms.
    Chen Z; Rosten SI; Lord EM; Gaspari AA
    Reg Immunol; 1993; 5(5):285-92. PubMed ID: 8148238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
    Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
    Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of Fas and FasL pro-apoptotic proteins in basal cell and squamous cell carcinomas.
    Wang XY; Zhang R; Lian S
    Clin Exp Dermatol; 2011 Jan; 36(1):69-76. PubMed ID: 20497185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression levels of testis-specific genes TEX101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features.
    Ghafouri-Fard S; Abbasi A; Moslehi H; Faramarzi N; Taba Taba Vakili S; Mobasheri MB; Modarressi MH
    Br J Dermatol; 2010 Apr; 162(4):772-9. PubMed ID: 19886887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-gamma-dependent type 1 immunity is crucial for immunosurveillance against squamous cell carcinoma in a novel mouse carcinogenesis model.
    Wakita D; Chamoto K; Ohkuri T; Narita Y; Ashino S; Sumida K; Nishikawa H; Shiku H; Togashi Y; Kitamura H; Nishimura T
    Carcinogenesis; 2009 Aug; 30(8):1408-15. PubMed ID: 19509217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population.
    Perrem K; Lynch A; Al Nooh F; Leader M; Elaine Kay
    Hum Pathol; 2008 Jul; 39(7):1034-41. PubMed ID: 18482746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma-induced ICAM-1 and CD40 expression, complete lack of HLA-DR and CD80 (B7.1), and inconsistent HLA-ABC expression in basal cell carcinoma: a possible role for interleukin-10?
    Kooy AJ; Prens EP; Van Heukelum A; Vuzevski VD; Van Joost T; Tank B
    J Pathol; 1999 Feb; 187(3):351-7. PubMed ID: 10398091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
    Bergfelt L
    Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.
    Stoebner PE; Le Gallic L; Berthe ML; Boulle N; Lallemant B; Marque M; Gaspard C; Delfour C; Lavabre-Bertrand T; Martinez J; Meunier L
    Exp Dermatol; 2008 Nov; 17(11):908-15. PubMed ID: 18341568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA molecule expression in cutaneous squamous cell carcinomas: an immunopathological study and clinical-immunohistopathological correlations.
    García-Plata D; Mozos E; Carrasco L; Solana R
    Histol Histopathol; 1993 Apr; 8(2):219-26. PubMed ID: 7683937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of urocanic acid isomers in human basal and squamous cell carcinoma tumors compared with tumor periphery and healthy skin.
    Decara JM; Aguilera J; Abdala R; Sánchez P; Figueroa FL; Herrera E
    Exp Dermatol; 2008 Oct; 17(10):806-12. PubMed ID: 18312386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinase-13 and Ki-67 in nonmelanoma skin cancer in xeroderma pigmentosum and non-xeroderma pigmentosum.
    El-Hawary AK; Yassin E; Khater A; Abdelgaber S
    Am J Dermatopathol; 2013 Feb; 35(1):45-9. PubMed ID: 22722466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
    Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
    Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunobiology of skin cancer.
    Dellon AL; Potvin C; Chretien PB; Rogentine CN
    Plast Reconstr Surg; 1975 Mar; 55(3):341-354. PubMed ID: 1078893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that dysregulated DNA mismatch repair characterizes human nonmelanoma skin cancer.
    Young LC; Listgarten J; Trotter MJ; Andrew SE; Tron VA
    Br J Dermatol; 2008 Jan; 158(1):59-69. PubMed ID: 17970804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.
    Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC
    J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
    Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
    Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.